Autoinjectors Market Size, Share & Growth Analysis By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Other), By Type (Disposable, Reusable), By Route Of Administration (Subcutaneous, Intramuscular) By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings), And Regional Forecast, 2021-2027

Report Summary

The Global Autoinjectors Market Size, Share & Growth Analysis By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Other), By Type (Disposable, Reusable), By Route Of Administration (Subcutaneous, Intramuscular) By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings), And Regional Forecast, 2021-2027, This research & consulting report doles out information about the global Autoinjectors market. The forecast period of the market extends till 2027, while commencing in 2020. The report sheds light on various key insights & trends that have occupied center stage & drawn the attention of end-users. The Autoinjectors industry is witnessing impressive expansion at present, having logged double digit CAGRs in the past.

The Global Autoinjectors Market was valued at USD 1,530.0 million in 2020, and is expected to reach USD 5,739.6 million by 2027, with a CAGR of 18.1% during the forecast period.

The report alludes to the Autoinjectors market as a lucrative sector. This sector is slated to generate substantial revenues during forecast period 2021 to 2027. The analytical report highlights data & overview regarding the size, shares, & demand of Autoinjectors. Several other factors have had a positive or negative impact on the industry, all of which have been laid out in details.

Pros & Scope of The Report

The said factors comprise drivers, novel prospects, hindrances, and other vital characteristics of the market. Investments by rivals into Autoinjectors products have catapulted the market into limelight & have stoked its demand, globally.

Few among other key aspects that find a mention; encompass the industry segments, predictions, & size and shares for 2021 to 2027. Besides these; the report narrows down on the innovative trends & technological developments, expansion strategies of key players, and regional statistics.

Some Of The Companies For Autoinjectors Market Are:

• Braun Melsungen AG
• AbbVie Inc.
• Mylan
• Eli Lilly and Company
• Ypsomed
• Amgen
• Becton, Dickinson and Company
• GlaxoSmithKline plc
• Johnson & Johnson
• Antares Pharma

More Inputs & Objectives

The manner in which nascent & local competitors stack up against prominent players, hogs the spotlight. Novel products & services, coupled with the monetary shares of eminent competitors and the SWOT analysis unveil the complexities of the global industry size.

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2021 to 2027 in each of the sub segments. For the purpose of this study, Eternity Insights has segmented the global Autoinjectors market on the basis of therapy, type, administration, end-use and region:

Autoinjectors Market, By Therapy

• Rheumatoid Arthritis
• Multiple Sclerosis
• Anaphylaxis
• Diabetes
• Others

Autoinjectors Market, By Type

• Disposable
• Reusable

Autoinjectors Market, By Route of Administration

• Subcutaneous
• Intramuscular

Autoinjectors Market, By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings

Autoinjectors Market, By Regional Outlook

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • BENELUX
  • Italy
  • Spain
  • Switzerland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Turkey
  • Rest of MEA

Research Methodology

Research methodology is an integral component of any kind of high-level market research. It entails evaluation by expert panels, research on secondary & primary levels, checks on quality, & testing on completion. Secondary research deeply focuses on the whys, whos, wheres, whens, & hows and caters to answering the strictly consumer-centric base of people.

Some other secondary research sources comprise governmental affiliations & blogs, business magazines, and industrial journals. Primary research includes face-to-face & telephonic interviews with industry experts. It is comparatively more detailed & lays stress on unprejudiced opinions about the products & services.

Primary research findings cement secondary research & help end-users & businesses get a better hang of various markets. It is a well-established fact, though, that research methodology is best implemented through the mixed execution of its aforementioned procedures.

What Does the Report Offer?

• A break down & profiling of the qualitative & quantitative analysis of the industry.
• An in-depth overview of the segments & sub-segments of the industry, unlocking their shares and positions.
• Data on market players & their growth strategies.
• Industry outlook, via value chains.
• Mergers & acquisitions, the SWOT analysis of prominent competitors, and high-tech product launches.
• Drivers, hindrances, factors that positively & negatively impact the market, and new opportunities.
• Crucial information and actionable insights, enabling businesses to widen their traction & to have an edge over others.
• Regions into which the global market is fragmented and the reigning regional markets & their respective shares & revenues.
• Analytical support on the purchases made/orders passed.

Other Vital Points That Are Covered

The impact of Covid-19 on each of the segments of the Autoinjectors market.

The suppliers, manufacturers, raw materials, dominating players, etc.

Key regional contributors & their shares in the past and the future.

Evaluation of most of the important countries within particular regions in view of their revenues, supplies, supremacy, business returns, & consumption volumes.

Advanced technologies that surround the market and comprehensive outlook on industry applications, products, end-users, & regions.

Technological & statistical data to cater to the demands of businesses, shareholders, & companies and to help them grow further.

Comparison of competitors against other players and the dominant companies during the forecast period. Strategies employed by reigning stakeholders to gain further traction & to generate higher revenues.

End users that are ahead in the rat race and the positive factors that influence those end users.

Applications that should come out on top by the end of the forecast period.

Products that occupy the maximum shares and the drivers behind those products.

Factors that bode well for the Autoinjectors market and a mention of other industries that are closely associated with the Autoinjectors market.

Regions that open the floodgates to higher investments and greater opportunities.

Records of the market sales, volumes, CAGRs, & shares.

The market report also brings to light major opportunities and untapped geographies. It is more like a blend of customized research documents & conventional reports. Besides informing buyers about the pros & cons of direct and indirect sales channels, the analysis exhibits illustrations & graphical representations of industry growth and the innovative trends within the industry.

 

Table Of Contents

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2017-2027

Chapter 3. Key Insights

Chapter 4. Global Autoinjectors Market Segmentation & Impact Analysis

    4.1. Global Autoinjectors Market Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Major prevalence of diabetes

                    4.2.2.2. Growing global geriatric population

          4.2.3. Market restraints analysis

                    4.2.3.1. High cost of autoinjectors devices

                    4.2.3.2. Availability of alternative drug delivery methods

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Global Autoinjectors Market Therapy Insights & Trends, Revenue (USD Billion)

    5.1. Therapy Dynamics & Market Share, 2017 & 2027

          5.1.1. Rheumatoid Arthritis

          5.1.2. Multiple Sclerosis

          5.1.3. Anaphylaxis

          5.1.4. Diabetes

          5.1.5. Others

Chapter 6. Global Autoinjectors Market Type Insights & Trends, Revenue (USD Billion)

    6.1. Type Dynamics & Market Share, 2017 & 2027

          6.1.1. Disposable

          6.1.2. Reusable

Chapter 7. Global Autoinjectors Market Route of Administration Insights & Trends, Revenue (USD Billion)

    7.1. Route of Administration Dynamics & Market Share, 2017 & 2027

          7.1.1. Subcutaneous

          7.1.2. Intramuscular

Chapter 8. Global Autoinjectors Market End-Use Insights & Trends Revenue (USD Billion)

    8.1. End-Use Dynamics & Market Share, 2017 & 2027

          8.1.1. Hospitals & Clinics

          8.1.2. Ambulatory Surgical Centers

          8.1.3. Home Care Settings

Chapter 9. Global Autoinjectors Market Regional Outlook

    9.1. Global Autoinjectors Market share By Region, 2017 & 2027

    9.2. North America

          9.2.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)

                    9.2.1.1. Rheumatoid Arthritis

                    9.2.1.2. Multiple Sclerosis

                    9.2.1.3. Anaphylaxis

                    9.2.1.4. Diabetes

                    9.2.1.5. Others

          9.2.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)

                    9.2.2.1. Disposable

                    9.2.2.2. Reusable

          9.2.3. Global Autoinjectors Market By Route of Administration, Market Estimates and Forecast, (USD Billion)

                    9.2.3.1. Subcutaneous

                    9.2.3.2. Intramuscular

          9.2.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)

                    9.2.4.1. Hospitals & Clinics

                    9.2.4.2. Ambulatory Surgical Centers

                    9.2.4.3. Home Care Settings

          9.2.5. Global Autoinjectors Market By Country, Estimates and Forecast, (USD Billion)

                    9.2.5.1. U.S.

                    9.2.5.2. Canada

                    9.2.5.3. Mexico

    9.3. Europe

          9.3.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)

                    9.3.1.1. Operating Microscopes

                    9.3.1.2. Micro Forceps

                    9.3.1.3. Micro Scissors

                    9.3.1.4. Micro Sutures

                    9.3.1.5. Microsurgery Needle Holders

                    9.3.1.6. Others

          9.3.2. Global Autoinjectors Market By Type, Estimates and Forecast, (USD Billion)

                    9.3.2.1. Disposable

                    9.3.2.2. Reusable

          9.3.3. Global Autoinjectors Market By Route of Administration, Estimates and Forecast, (USD Billion)

                    9.3.3.1. Subcutaneous

                    9.3.3.2. Intramuscular

          9.3.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)

                    9.3.4.1. Hospitals & Clinics

                    9.3.4.2. Ambulatory Surgical Centers

                    9.3.4.3. Home Care Settings

          9.3.5. Market By Country, Estimates and Forecast, (USD Billion)

                    9.3.5.1. Germany

                    9.3.5.2. France

                    9.3.5.3. U.K.

                    9.3.5.4. BENELUX

                    9.3.5.5. Italy

                    9.3.5.6. Spain

                    9.3.5.7. Switzerland

                    9.3.5.8. Russia

                    9.3.5.9. Rest of Europe

    9.4. Asia Pacific

          9.4.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)

                    9.4.1.1. Rheumatoid Arthritis

                    9.4.1.2. Multiple Sclerosis

                    9.4.1.3. Anaphylaxis

                    9.4.1.4. Diabetes

                    9.4.1.5. Others

          9.4.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)

                    9.4.2.1. Disposable

                    9.4.2.2. Reusable

          9.4.3. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)

                    9.4.3.1. Hospitals & Clinics

                    9.4.3.2. Ambulatory Surgical Centers

                    9.4.3.3. Home Care Settings

          9.4.4. Market By Country, Estimates and Forecast, (USD Billion)

                    9.4.4.1. China

                    9.4.4.2. Japan

                    9.4.4.3. South Korea

                    9.4.4.4. India

                    9.4.4.5. Rest of APAC

    9.5. Latin America

          9.5.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)

                    9.5.1.1. Rheumatoid Arthritis

                    9.5.1.2. Multiple Sclerosis

                    9.5.1.3. Anaphylaxis

                    9.5.1.4. Diabetes

                    9.5.1.5. Others

          9.5.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)

                    9.5.2.1. Rheumatoid Arthritis

                    9.5.2.2. Multiple Sclerosis

                    9.5.2.3. Anaphylaxis

                    9.5.2.4. Diabetes

                    9.5.2.5. Others

          9.5.3. Global Autoinjectors Market By Route of Administration, Market Estimates and Forecast, (USD Billion)

                    9.5.3.1. Subcutaneous

                    9.5.3.2. Intramuscular

          9.5.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)

                    9.5.4.1. Hospitals & Clinics

                    9.5.4.2. Ambulatory Surgical Centers

                    9.5.4.3. Home Care Settings

          9.5.5. Market By Country, Estimates and Forecast, (USD Billion)

                    9.5.5.1. Brazil

                    9.5.5.2. Rest of LATAM

    9.6. Middle East & Africa

          9.6.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)

                    9.6.1.1. Rheumatoid Arthritis

                    9.6.1.2. Multiple Sclerosis

                    9.6.1.3. Anaphylaxis

                    9.6.1.4. Diabetes

                    9.6.1.5. Others

          9.6.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)

                    9.6.2.1. Disposable

                    9.6.2.2. Reusable

          9.6.3. Global Autoinjectors Market By Route of Administration, Market Estimates and Forecast, (USD Billion)

                    9.6.3.1. Subcutaneous

                    9.6.3.2. Intramuscular

          9.6.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)

                    9.6.4.1. Hospitals & Clinics

                    9.6.4.2. Ambulatory Surgical Centers

                    9.6.4.3. Home Care Settings

          9.6.5. Market By Country, Estimates and Forecast, (USD Billion)

                    9.6.5.1. Saudi Arabia

                    9.6.5.2. UAE

                    9.6.5.3. South Africa

                    9.6.5.4. Turkey

                    9.6.5.5. Rest of MEA

Chapter 10. Competitive Landscape

    10.1. Market Revenue Share By Manufacturers

    10.2. Mergers & Acquisitions

    10.3. Competitor’s Positioning

    10.4. Strategy Benchmarking

    10.5. Suppliers Landscape

    10.6. Raw Material suppliers

          10.6.1. North America

          10.6.2. Europe

          10.6.3. Asia Pacific

          10.6.4. Middle East & Africa

          10.6.5. Latin America

    10.7. Service Providers

          10.7.1. North America

          10.7.2. Europe

          10.7.3. Asia Pacific

          10.7.4. Middle East & Africa

          10.7.5. Latin America

          10.7.6. Others

Chapter 11. Company Profiles                   

    11.1. B. Braun Melsungen AG

          11.1.1. Company Overview

          11.1.2. Financial Performance

          11.1.3. Technology Insights

          11.1.4. Strategic Initiatives

          11.1.5. Eternity Insights

    11.2. AbbVie Inc.

          11.2.1. Company Overview

          11.2.2. Financial Performance

          11.2.3. Technology Insights

          11.2.4. Strategic Initiatives

          11.2.5. Eternity Insights

    11.3. Mylan

          11.3.1. Company Overview

          11.3.2. Financial Performance

          11.3.3. Technology Insights

          11.3.4. Strategic Initiatives

          11.3.5. Eternity Insights

    11.4. Eli Lilly and Company

          11.4.1. Company Overview

          11.4.2. Financial Performance

          11.4.3. Technology Insights

          11.4.4. Strategic Initiatives

          11.4.5. Eternity Insights

    11.5. Ypsomed

          11.5.1. Company Overview

          11.5.2. Financial Performance

          11.5.3. Technology Insights

          11.5.4. Strategic Initiatives

          11.5.5. Eternity Insights

    11.6. Amgen

          11.6.1. Company Overview

          11.6.2. Financial Performance

          11.6.3. Technology Insights

          11.6.4. Strategic Initiatives

          11.6.5. Eternity Insights

    11.7. Becton, Dickinson and Company

          11.7.1. Company Overview

          11.7.2. Financial Performance

          11.7.3. Technology Insights

          11.7.4. Strategic Initiatives

          11.7.5. Eternity Insights

    11.8. GlaxoSmithKline plc

          11.8.1. Company Overview

          11.8.2. Financial Performance

          11.8.3. Technology Insights

          11.8.4. Strategic Initiatives

          11.8.5. Eternity Insights

    11.9. Johnson & Johnson

          11.9.1. Company Overview

          11.9.2. Financial Performance

          11.9.3. Technology Insights

          11.9.4. Strategic Initiatives

          11.9.5. Eternity Insights

    11.10. Antares Pharma

          11.10.1. Company Overview

          11.10.2. Financial Performance

          11.10.3. Technology Insights

          11.10.4. Strategic Initiatives

          11.10.5. Eternity Insights